News
Terumo Neuro (formerly MicroVention) announced today that it received FDA premarket approval (PMA) for its Carotid Stent ...
EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...
Imperative Care announced that it intends to fund a trial comparing its Zoom stroke system plus best medical treatment to ...
Lifeward (Nasdaq:LFWD) announced today that it launched the next-generation ReWalk 7 personal exoskeleton in the United States.
DESKi today announced FDA clearance of HeartFocus, its AI-enabled heart exam software. Bordeaux, France–based DESKi says it only takes a few hours of training for any healthcare professional, ...
Phantom Neuro announced today that it raised $19 million in a Series A funding round to support its neural interface technology.
CeriBell (Nasdaq:CBLL) announced today that it received FDA 510(k) clearance for its next-generation Ceribell Clarity algorithm.
Johnson & Johnson (NYSE: JNJ) shares dipped slightly today on first-quarter results that came in ahead of the consensus forecast.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results